Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 2.5%. By the end of trading, Thermo Fisher Scientific fell $3.03 (-3.6%) to $81.66 on average volume. Throughout the day, 3,684,753 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 2,982,200 shares. The stock ranged in price between $81.18-$83.74 after having opened the day at $83.73 as compared to the previous trading day's close of $84.69. Other companies within the Health Services industry that declined today were:
), down 61.5%,
), down 22.2%,
), down 8.8% and
), down 8.4%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $30.9 billion and is part of the health care sector. The company has a P/E ratio of 23.9, above the S&P 500 P/E ratio of 17.7. Shares are up 32.8% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.
TheStreet Ratings rates
Thermo Fisher Scientific
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full Thermo Fisher Scientific Ratings Report.
On the positive front,
), down 4.2%,
), down 3.6%,
), down 3.3% and
), down 3.2%.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider
) while those bearish on the health services industry could consider
- Find other investment ideas from our top rated ETFs lists.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.